Skip to content
Antivirals — Viral protease inhibitors

Nirmatrelvir–ritonavir

Prescription only

COVID-19 antiviral pills for people at high risk.

Starts working
Varies
Half-life
About 6 hours
In use since
2021
Pregnancy
Use with caution

Overview

Paxlovid is a 5-day treatment for COVID-19 in people at high risk of severe illness. Nirmatrelvir blocks the virus; ritonavir boosts its levels by blocking liver enzymes — which is also why it interacts with many common medicines.

Conditions it's used for

How it works

Blocks the enzyme the coronavirus uses to cut its proteins into working parts.

Nirmatrelvir–ritonavir belongs to the Viral protease inhibitors. How Viral protease inhibitors work: block the viral 'scissors' enzyme, so the long protein chain the virus makes cannot be cut into working pieces.

Uses

  • Mild to moderate COVID-19 in people at high risk of severe disease

Available as: co-packaged tablets.

Typical dose

Adults
300 mg nirmatrelvir + 100 mg ritonavir twice a day for 5 days, started within 5 days of symptoms (lower dose in moderate kidney disease).

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Altered taste ('Paxlovid mouth')
  • Diarrhoea
  • Nausea

Serious — get medical help

Uncommon, but need prompt attention

  • Dangerous interactions with other medicines
  • Allergic reactions

Warnings

  • Every other medicine must be checked first
  • Some medicines must be paused, others mean Paxlovid can't be used

Interactions

  • Simvastatin, colchicine, some antiarrhythmics and sedatives — contraindicated
  • Tacrolimus, ciclosporin — dangerous rises
  • DOACs, many others — dose changes

Other medicines in the atlas that need care with Nirmatrelvir–ritonavir, grouped by the reason:

Dangerous rise in drug levelsMajorWith Ciclosporin, Colchicine, Fentanyl, Midazolam, Simvastatin and 3 more

A strong CYP3A4 inhibitor blocks breakdown of a drug where higher levels are hazardous (e.g. simvastatin — muscle breakdown; colchicine — fatal toxicity; tacrolimus — kidney damage; fentanyl or midazolam — breathing suppression).

What's usually done: Usually contraindicated or needs a planned pause or major dose change. Always check with a pharmacist.

More anticoagulant effectMajorWith Apixaban, Dabigatran, Edoxaban, Rivaroxaban

Combined P-glycoprotein and strong CYP3A4 inhibition can raise apixaban or rivaroxaban exposure and increase bleeding.

What's usually done: Follow the apixaban or rivaroxaban label: avoid or reduce the DOAC dose as directed with strong dual inhibitors.

Colchicine toxicityMajorWith Colchicine

Transporter inhibition can raise colchicine exposure; toxicity may cause severe diarrhoea, muscle injury, bone-marrow suppression or organ failure.

What's usually done: Avoid many combinations, especially with kidney or liver disease. Use a lower dose only under specialist advice.

Digoxin toxicityMajorWith Digoxin

P-glycoprotein inhibition can raise digoxin levels, increasing the risk of nausea, visual changes, confusion and dangerous heart rhythms.

What's usually done: Check the digoxin level and kidney function; a dose reduction may be needed.

Raised drug levelsModerateWith Abiraterone, Alfuzosin, Alprazolam, Amlodipine, Apremilast and 55 more
Higher rhythm riskModerateWith Amiodarone, Amisulpride, Amitriptyline, Artemether–lumefantrine, Azithromycin and 38 more
Low blood sugarModerateWith Glibenclamide, Gliclazide, Glimepiride, Glipizide

Some CYP3A4 inhibitors increase exposure to sulfonylureas, making hypoglycaemia more likely.

What's usually done: Check glucose more often and review the diabetes dose when the inhibitor starts or stops.

INR may riseModerateWith Warfarin

Some CYP3A4 inhibitors can slow warfarin metabolism and increase anticoagulant effect.

What's usually done: Check INR soon after starting or stopping the inhibitor and adjust warfarin only through the anticoagulation service.

Check Nirmatrelvir–ritonavir against your own medicines

Pregnancy and breastfeeding

Use with caution

Can be used if benefits outweigh risks; limited data.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Paxlovid
United Kingdom
Paxlovid
Australia
Paxlovid

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

History

  1. 2021

    Emergency authorisation in the US (December).

  2. 2023

    Full FDA approval.

Rebound — symptoms returning a few days after finishing — happens in a minority of people, with or without Paxlovid.

Common questions

Can I take it if I'm on a statin?

Some statins are paused during treatment; others need no change. A pharmacist can check your list.

Do I need a prescription for Nirmatrelvir–ritonavir?

Yes — Nirmatrelvir–ritonavir is prescription-only in most countries.

Can I take Nirmatrelvir–ritonavir during pregnancy?

Use with caution. Can be used if benefits outweigh risks; limited data. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.